Similarly, recently it was found that upregulation of miR-361-3p inhibited MM cells viability and enhanced apoptosis through targeting tumor necrosis factor receptor-associated factor 6 (TRAF6) (45). Here, TRAF6 is linked to Miyoshi myopathy.